Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Tatsuo Masubuchi"'
Autor:
Yukiomi Kushihashi, Tatsuo Masubuchi, Isaku Okamoto, Chihiro Fushimi, Morio Yamazaki, Hisashi Asano, Reo Aoki, Shota Fujii, Yukiko Asako, Yuichiro Tada
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 471-476 (2024)
Introduction: Photoimmunotherapy (PIT) is a treatment wherein intravenous cetuximab sarotalocan sodium is administered followed by laser light irradiation. This treatment exhibits a specific antitumor effect if in tumors expressing the epidermal grow
Externí odkaz:
https://doaj.org/article/47ece69ba8be487dbda8ad1ae451692f
Autor:
Kunihiko Tokashiki, Isaku Okamoto, Takuro Okada, Hiroki Sato, Taku Yamashita, Takashi Matsuki, Takahito Kondo, Chihiro Fushimi, Tatsuo Masubuchi, Kouki Miura, Go Omura, Kiyoaki Tsukahara
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 5, p 1464 (2022)
This study compared the incidence of perioperative complications and swallowing function between free jejunal flap reconstruction and cutaneous free tissue flap construction. We included 223 patients who underwent hypopharyngeal reconstruction using
Externí odkaz:
https://doaj.org/article/d5c18ca6a6e144608b79d713149d6dd7
Autor:
Takashi Matsuki, Kouki Miura, Yuichiro Tada, Tatsuo Masubuchi, Chihiro Fushimi, Yoshihiro Nitta, Shinetsu Kamata, Isaku Okamoto, Shunsuke Miyamoto, Taku Yamashita
Publikováno v:
Otolaryngology Case Reports, Vol 13, Iss , Pp - (2019)
Background: Occupied lesions arising in the parapharyngeal space (PPS) are rare. Among these, venous malformations are particularly rare, and very few case reports have appeared. Methods: Two patients with venous malformations in the PPS were operate
Externí odkaz:
https://doaj.org/article/ea29710efa4d4ae194982c790ea0006c
Autor:
Takashi Matsuki, Isaku Okamoto, Chihiro Fushimi, Hideaki Takahashi, Takuro Okada, Takahito Kondo, Hiroki Sato, Tatsuya Ito, Kunihiko Tokashiki, Kiyoaki Tsukahara, Kenji Hanyu, Tatsuo Masubuchi, Yuichiro Tada, Kouki Miura, Go Omura, Michi Sawabe, Daisuke Kawakita, Taku Yamashita
Publikováno v:
Cancers, Vol 12, Iss 11, p 3427 (2020)
No real-world, long-term outcomes of immunotherapy with nivolumab for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) have yet been reported. Furthermore, the prognostic impact of the best overall response (BOR) of th
Externí odkaz:
https://doaj.org/article/036865f0096b454d8156567c49cb13b1
Autor:
Chihiro Matsui, MD, Orgun Doruk, MD, Takakuni Tanaka, DDS, Chihiro Fushimi, DDS, Tatsuo Masubuchi, MD, PhD, Kouki Miura, MD, PhD, Hiroshi Mizuno, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 9S, Pp 11-12 (2018)
Externí odkaz:
https://doaj.org/article/b01045a95cb34e08a54fd0f1af089ef0
Autor:
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, KUNIHIKO TOKASHIKI, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, TATSUO MASUBUCHI, YUICHIRO TADA, KOKI MIURA, GO OMURA, TAKU YAMASHITA, NOBUHIKO ORIDATE, KIYOAKI TSUKAHARA
Publikováno v:
Anticancer Research. 43:2717-2724
Autor:
TAKASHI MATSUKI, CHIHIRO FUSHIMI, SHUNSUKE MIYAMOTO, HIDEAKI TAKAHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, SHIN-ETSU KAMATA, KOICHI KANO, SHOHEI TSUTSUMI, KAHO MOMIYAMA, TAKU YAMASHITA
Publikováno v:
Anticancer Research. 42:3177-3183
In patients with squamous cell carcinoma of the head and neck (SCCHN), delayed surgery can result in poorer postoperative function and prognosis due to the growth of the tumor and extended surgery. Further, delay may even make the tumor unresectable.
Autor:
TAKURO OKADA, CHIHIRO FUSHIMI, TAKASHI MATSUKI, ISAKU OKAMOTO, HIROKI SATO, TAKAHITO KONDO, KUNIHIKO TOKASHIKI, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, YUSUKE AIHARA, KENJI HANYU, YUKIOMI KUSHIHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, YUKI HARADA, KAHO MOMIYAMA, TAKU YAMASHITA, GO OMURA, HIDEAKI TAKAHASHI, NOBUHIKO ORIDATE, KIYOAKI TSUKAHARA
Publikováno v:
Anticancer Research. 42:1607-1613
There are no real-world comparative data of nivolumab doses of 3 mg/kg and 240 mg/body for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). We investigated the efficacy and safety of nivolumab in treating recurrent/metas
Autor:
Chihiro Fushimi, Yuichiro Tada, Tatsuo Masubuchi, Morio Yamazaki, Kenji Hanyu, Naruhisa Tanaka, Yukiomi Kushihashi, Mayu Yamauchi, Satomi Sugiyama, Kouki Miura
Publikováno v:
Toukeibu Gan. 48:14-20
Autor:
Yukiomi Kushihashi, Chihiro Fushimi, Tatsuo Masubuchi, Kenji Hanyu, Yuichiro Tada, Koki Miura
Publikováno v:
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY. 32:1-7